About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Mental Practice in Parkinson's Disease | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT02729454

Mental Practice in Parkinson's Disease

Introduction Although drug therapy is the mainstay of treatment for Parkinson's disease, the therapy also has its importance by means of exercises which maintains the muscular activity and preserve mo...

Lead sponsor: Universidade Federal de Pernambuco•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Universidade Federal de Pernambuco

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients with clinical diagnosis of idiopathic Parkinson's disease
•Male and female
•Stage 1-3 of the Hoehn and Yahr scale.

Exclusion Criteria

•Have other neurological diseases
•They have decompensated systemic diseases
•Musculoskeletal changes that prevent the achievement of movements
•With lowering of the cognitive level assessed using the Mini-Mental State Examination with cutoff point according to education
•With respiratory impairment
•With medical restrictions for performing exercises
•Do not get hold motor imagination during the application of Visual and Kinesthetic Imagery Questionnaire-10
•In physical therapy, occupational therapy service for 3 months or more;
•Patients with moderate to severe depression assessed by inventory Beck Depression Inventory

Related studies

Apathy in Parkinson Disease TMS Study

NCT06087926 · Parkinson Disease

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

NCT07642908 · Parkinson Disease

RECRUITINGPhase 2

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

NCT06680830 · Parkinson Disease, Parkinson, and more

Cognitive Decline Following Deep Brain Stimulation

NCT05822388 · Parkinson Disease, Movement Disorders

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

NCT06965374 · Parkinson Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 28, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment18

Start dateOct 2015

Last updatedSep 28, 2016

Condition

Parkinson Disease

Locations shown

Hospital Das Clinicas - Ufpe

Recife, Pernambuco

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 28, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions